Patents by Inventor Nikita Oskolkov

Nikita Oskolkov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11235075
    Abstract: The present invention provides novel hydrogels through peptides, which are designed to self-assemble and produce magnetic resonance (MR) contrast through chemical exchange saturation transfer (CEST). The location and integrity of these gels could consequently be tracked using MR imaging. The self-assembly of the peptides into hydrogels can be brought about by a change in pH, ionic strength, temperature, and concentration of ions.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: February 1, 2022
    Assignees: THE JOHNS HOPKINS UNIVERSITY, KENNEDY KRIEGER INSTITUTE, INC., NATIONAL INSTITUTES OF HEALTH
    Inventors: Michael T. McMahon, Kannie Wai-Yan Chan, Michael Christopher Giano, Nikita Oskolkov, Joel Patrick Schneider, Xiaolei Song
  • Patent number: 10898594
    Abstract: PAMAM dendrimer based CEST imaging agents, pharmaceutical compositions comprising the same and methods of uses thereof are disclosed.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: January 26, 2021
    Assignee: The Johns Hopkins University
    Inventors: Wojciech Lesniak, Sridhar Nimmagadda, Nikita Oskolkov, Michael McMahon, Xiaolei Song, Martin G. Pomper
  • Patent number: 10568975
    Abstract: Surface conjugated diamagnetic Chemical Exchange Saturation Transfer (diaCEST) agent carriers and methods of making and using are described herein. The particles are safe alternatives to conventional paramagnetic or superparamagnetic metal-based MRI contrast agents that are often toxic and therefore not biocompatible. The carriers described herein can provide simultaneous monitoring of multiple particle types labeled with ‘multicolor’ diaCEST contrast agents. In some embodiments, the carriers are micro- and/or nanoparticles. In other embodiments, the carriers are liposomes. In some embodiments, the particles and/or liposomes are mucus penetrating. In other embodiments, the particles and/or liposomes are not mucus penetrating.
    Type: Grant
    Filed: February 5, 2014
    Date of Patent: February 25, 2020
    Assignee: The Johns Hopkins University
    Inventors: Tao Yu, Himatkumar Patel, Kannie M. Y. Chan, Nikita Oskolkov, Michael McMahon, Justin Hanes
  • Publication number: 20190060490
    Abstract: PAMAM dendrimer based CEST imaging agents, pharmaceutical compositions comprising the same and methods of uses thereof are disclosed.
    Type: Application
    Filed: October 27, 2016
    Publication date: February 28, 2019
    Inventors: WOJCIECH LESNIAK, SRIDHAR NIMMAGADDA, NIKITA OSKOLKOV, MICHAEL MCMAHON, XIAOLEI SONG, MARTIN G. POMPER
  • Publication number: 20160206760
    Abstract: Surface conjugated diamagnetic Chemical Exchange Saturation Transfer (diaCEST) agent carriers and methods of making and using are described herein. The particles are safe alternatives to conventional paramagnetic or superparamagnetic metal-based MRI contrast agents that are often toxic and therefore not biocompatible. The carriers described herein can provide simultaneous monitoring of multiple particle types labeled with ‘multicolor’ diaCEST contrast agents. In some embodiments, the carriers are micro- and/or nanoparticles. In other embodiments, the carriers are liposomes. In some embodiments, the particles and/or liposomes are mucus penetrating. In other embodiments, the particles and/or liposomes are not mucus penetrating.
    Type: Application
    Filed: February 5, 2014
    Publication date: July 21, 2016
    Inventors: Tao Yu, Himatkumar Patel, Kannie M.Y. Chan, Nikita Oskolkov, Michael McMahon, Justin Hanes
  • Publication number: 20160106871
    Abstract: The present invention provides novel hydrogels through peptides, which are designed to self-assemble and produce magnetic resonance (MR) contrast through chemical exchange saturation transfer (CEST). The location and integrity of these gels could consequently be tracked using MR imaging. The self-assembly of the peptides into hydrogels can be brought about by a change in pH, ionic strength, temperature, and concentration of ions.
    Type: Application
    Filed: April 28, 2014
    Publication date: April 21, 2016
    Applicants: The Johns Hopkins University, Kennedy Krieger Institute, Inc., National Institute of Health
    Inventors: Michael T. McMahon, Kannie Wai-Yan Chan, Michael Christopher Giano, Nikita Oskolkov, Joel Patrick Schneider, Xiaolei Song
  • Publication number: 20150133768
    Abstract: The present invention includes drug-loaded, polymer nanoparticles and liposomes further incorporating a non-paramagnetic, bioorganic CEST agent. The CEST agent allows for an alternative approach to accomplish MR-compatible in vivo tracking of drug-loaded polymer nanoparticles and liposomes, including simultaneous multi-color mapping of more than one particle type, or of the same particle type delivered via two different routes (e.g., systemic versus local). Additionally, the present invention can include a library of biodegradable diamagnetic (DIA)CEST agents. These DIACEST agents can be incorporated into nanoparticle-based delivery systems, such as stealth liposomes loaded with doxorubicin and stealth polymer nanoparticles loaded with paclitaxel. These systems can be tracked, according to an embodiment of the present invention using CEST-based MRI (compared to SPECT/CT) as a method to monitor the efficiency with which the nanoparticles reach the targeted tumors and how long they persist.
    Type: Application
    Filed: April 17, 2013
    Publication date: May 14, 2015
    Inventors: Michael T. McMahon, Kannie W.Y. Chan, Guanshu Liu, Jeff W.M. Bulte, Nikita Oskolkov
  • Publication number: 20140038281
    Abstract: The present invention relates to a system for intracellular cargo delivery, named NickFect, comprising at least one component A, which is attached covalently to cell penetrating peptide B and/or peptide or non-peptide construct C. The said delivery system NickFect relates to chemically modified new cell-penetrating peptides (CPP) non-covalently or covalently complexed with cargo for efficient cellular.
    Type: Application
    Filed: February 22, 2012
    Publication date: February 6, 2014
    Applicant: CEPEP III AB
    Inventors: Ülo Langel, Piret Arukuusk, Nikita Oskolkov, Dana Maria Copolovici